Evidence map›Paper›PMID 27334470›Full record

ArticleBMC genomics2016

Genomic analysis of nontypeable pneumococci causing invasive pneumococcal disease in South Africa, 2003-2013.

Thabo Mohale, Nicole Wolter, Mushal Allam, Kedibone Ndlangisa, Penny Crowther-Gibson, Mignon du Plessis, Anne von Gottberg

Open access · goldAbstract readHistorical Article
In one paragraph

Article in BMC genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. An abundance ofMicrobiology (Reading, England) · 2025
    Article
  4. AliC and AliD of nonencapsulatedFrontiers in cellular and infection microbiology · 2025
    Article
  5. Article
  6. Observational
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Thabo MohaleCentre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), National Health Laboratory Services (NHLS), Johannesburg, South Africa. thabom@nicd.ac.za.
Nicole WolterCentre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), National Health Laboratory Services (NHLS), Johannesburg, South Africa.
Mushal AllamCentre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), National Health Laboratory Services (NHLS), Johannesburg, South Africa.
Kedibone NdlangisaCentre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), National Health Laboratory Services (NHLS), Johannesburg, South Africa.
Penny Crowther-GibsonPublic Health Surveillance and Response, National Institute for Communicable Diseases, National Health Laboratory Services, Johannesburg, South Africa.
Mignon du PlessisCentre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), National Health Laboratory Services (NHLS), Johannesburg, South Africa.
Anne von GottbergCentre for Respiratory Diseases and Meningitis (CRDM), National Institute for Communicable Diseases (NICD), National Health Laboratory Services (NHLS), Johannesburg, South Africa.
National Health Laboratory Service · ZAUniversity of the Witwatersrand · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe capsular polysaccharide is the principal virulence factor of Streptococcus pneumoniae and a target for current pneumococcal vaccines. However, some pathogenic pneumococci are serologically nontypeable [nontypeable pneumococci (NTPn)]. Due to their relative rarity, NTPn are poorly characterized, and, as such, limited data exist which describe these organisms. We aimed to describe disease and genotypically characterize NTPn causing invasive pneumococcal disease in South Africa.

resultsIsolates were detected through national, laboratory-based surveillance for invasive pneumococcal disease in South Africa and characterized by whole genome analysis. We predicted ancestral serotypes (serotypes from which NTPn may have originated) for Group I NTPn using multilocus sequence typing and capsular region sequence analyses. Antimicrobial resistance patterns and mutations potentially causing nontypeability were identified. From 2003-2013, 39 (0.1 %, 39/32,824) NTPn were reported. Twenty-two (56 %) had partial capsular genes (Group I) and 17 (44 %) had complete capsular deletion of which 15 had replacement by other genes (Group II). Seventy-nine percent (31/39) of our NTPn isolates were derived from encapsulated S. pneumoniae. Ancestral serotypes 1 (27 %, 6/22) and 8 (14 %, 3/22) were most prevalent, and 59 % (13/22) of ancestral serotypes were serotypes included in the 13-valent pneumococcal conjugate vaccine. We identified a variety of mutations within the capsular region of Group I NTPn, some of which may be responsible for the nontypeable phenotype. Nonsusceptibility to tetracycline and erythromycin was higher in NTPn than encapsulated S. pneumoniae.

conclusionsNTPn are currently a rare cause of invasive pneumococcal disease in South Africa and represent a genetically diverse collection of isolates.

Indexed as

Genome, BacterialGenomicsAnti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialGenotypeHigh-Throughput Nucleotide SequencingHistory, 21st CenturyHumansMultilocus Sequence TypingPhylogenyPneumococcal InfectionsPopulation SurveillanceSerotypingSouth AfricaStreptococcus pneumoniaeAnti-Bacterial AgentsBacterial ProteinsInvasive pneumococcal diseaseNontypeableSouth AfricaStreptococcus pneumoniaeWhole genome sequencing

Identifiers

PMID27334470
PMCPMC4928513
OpenAlexW2462176022

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.